Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease
about
sameAs
Molecular markers of early Parkinson's disease based on gene expression in bloodParkin counteracts symptoms in a Drosophila model of Parkinson's disease.Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivoAcyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolismWhole transcriptome analysis of a reversible neurodegenerative process in Drosophila reveals potential neuroprotective genes.Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.Isotopolog perturbation techniques for metabolic networks: metabolic recycling of nutritional glucose in Drosophila melanogasterAssociation of cytochrome b5 with ETR1 ethylene receptor signaling through RTE1 in Arabidopsis.The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models.Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease.Drosophila melanogaster in the study of human neurodegeneration.Parkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease.Functional genomics in Drosophila models of human disease.SKN-1/Nrf2 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of methylmercury toxicity.α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies.Drosophila models of neurodegenerative diseases.Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.Bridging molecular genetics and biomarkers in lewy body and related disordersWhat we can learn from animal models about cerebral multi-morbidity.Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouseGenes and pathways affected by CAG-repeat RNA-based toxicity in DrosophilaThe pugilistDominant Mutation of Drosophila melanogaster: A Simple-Sequence Repeat Disorder Reveals Localized Transport in the Eye.Polyunsaturated fatty acids induce alpha-synuclein-related pathogenic changes in neuronal cellsAltered gene expression profiles reveal similarities and differences between Parkinson disease and model systems.Identification of novel genes that modify phenotypes induced by Alzheimer's beta-amyloid overexpression in DrosophilaMicroarrays in Parkinson's disease: a systematic approach.Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease.Protein expression in a Drosophila model of Parkinson's disease.Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive elementRecent advances in using Drosophila to model neurodegenerative diseases.Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities.Understanding and treating neurodegeneration: insights from the flies.Pla2g6 Deficiency in Zebrafish Leads to Dopaminergic Cell Death, Axonal Degeneration, Increased β-Synuclein Expression, and Defects in Brain Functions and Pathways.The dietary supplementation of nordihydroguaiaretic acid (NDGA) delayed the loss of climbing ability in Drosophila model of Parkinson's disease.Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein.Drosophila melanogaster White Mutant w1118 Undergo Retinal Degeneration.Impaired Wnt signaling in dopamine containing neurons is associated with pathogenesis in a rotenone triggered Drosophila Parkinson's disease model.Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis.
P2860
Q24292810-D020A158-A3FF-46A5-B655-A62F472EEB78Q24803129-CDA8BB2E-70BD-4036-9CA3-7AF02A848076Q27346877-9B833FBD-12D2-48D7-8AFC-9D7EBB59AD74Q28586519-1940C149-ED92-4A0B-AD81-62F26544D62EQ30528302-C03D2BD6-3942-4B11-89EC-E24CC6886C32Q30856480-469454A1-7F2A-4F60-99C7-AFF18FC1B6D6Q30923544-3B2484BB-742D-4FDA-B9F7-61B5D8A6A652Q33692973-34C478A6-98BB-4E37-8D3B-22BA7BF5A8F4Q33898316-76F3802B-8A17-4A50-B432-6C6126407160Q33906476-A96B9D84-0297-4759-91D1-DF212522B81BQ34022667-E2C2DCF8-9712-400C-AD98-6925FA954EB4Q34301507-4E42D946-8DB8-4BF0-80A6-4680CFF82F39Q34390078-5BB647A3-44EC-44BB-9D1D-0707491C703BQ34413384-FDCA1A58-A083-4A37-910E-066C0781A130Q34442714-95775F0F-B840-4581-BDE7-3CFB68F2F9D8Q34610331-65EB77ED-0DAA-4E1C-B9AA-BF11F9934ED8Q34648491-3B401519-497E-4DF0-9580-20E6925E20C7Q35094391-E1F8517F-D629-470B-9494-C3510722A7EAQ35215656-04519E5D-96A2-4ED1-BF04-2DC23C8F95A9Q35345762-F917620D-B6AA-48DD-B256-94489914E7B3Q35565702-C0AA178D-098E-4ACD-96C8-AED713E8B5FFQ35964841-5A20C2A9-F472-4595-8E9E-7A542F823AB1Q36202906-79B6EC03-FA5E-498F-820C-05CC2A6B95A1Q36311189-B67446D4-A58C-493C-8BD1-BB1F0BCC37C5Q36515716-49628F6A-D087-4E9B-9AF7-314540A362FCQ36525157-4327D093-48DC-42DE-8E0A-941BE9A06A11Q36804685-72968156-DC43-4C08-BE3B-D6B6059B4978Q37002789-F286362F-3236-4096-B4B8-1A2E9745E895Q37166339-FD5ADF60-C91A-4B90-BFEE-1A81FAEEF085Q37448324-8DC93DDD-4FCA-411D-A2C3-2EA7B98D79D4Q37809870-8FE57EC3-EB4D-4C91-BF42-ECFE629B7DD6Q41949061-A9DD7DE5-E077-4899-B1A7-191B66408E76Q47854549-31FD3C51-BA4B-4836-9C6B-EBA5EB39D36FQ48606050-3A3431F0-4601-4D3C-BB1D-5667120F8C22Q48624696-8E055054-C2F5-4E84-B53F-D9C0B93FFD19Q49269105-50B9A58F-F04B-44F7-8F99-78C6757D5543Q49417153-915CE2DA-6B93-45ED-8DCA-E6E3EA1412BDQ52655035-D760CB1B-CABC-46ED-A4FE-F6F54C47E72A
P2860
Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Gene expression changes presag ...... a model of Parkinson's disease
@ast
Gene expression changes presag ...... a model of Parkinson's disease
@en
Gene expression changes presag ...... a model of Parkinson's disease
@nl
type
label
Gene expression changes presag ...... a model of Parkinson's disease
@ast
Gene expression changes presag ...... a model of Parkinson's disease
@en
Gene expression changes presag ...... a model of Parkinson's disease
@nl
prefLabel
Gene expression changes presag ...... a model of Parkinson's disease
@ast
Gene expression changes presag ...... a model of Parkinson's disease
@en
Gene expression changes presag ...... a model of Parkinson's disease
@nl
P2093
P3181
P356
P1476
Gene expression changes presag ...... a model of Parkinson's disease
@en
P2093
Clemens R Scherzer
Mel B Feany
Roderick V Jensen
Steven R Gullans
P304
P3181
P356
10.1093/HMG/DDG265
P407
P577
2003-10-01T00:00:00Z